April 29, 2013 5:11 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NASDAQ: ESRX) were up around 2 percent to $59.52 in Monday's after hours trading session after the company released its fiscal first-quarter financial results after the closing bell. Express Scripts reported net income of $373.0 million or $0.45 per share, versus $267.8 million or $0.55 per share, in last year's corresponding period. The discrepancy in EPS was due to a rise in the company's outstanding shares to 832.5 million from 489.7 million in last year's corresponding quarter. Adjusted net income for the quarter was $0.99 per share, versus $0.73 per share in last year's first-quarter. This came in above Wall Street analysts' consensus EPS estimates of $0.97. Revenue in the quarter was $26.06 billion from $12.13 billion last year. The jump in revenue was attributable to Express Scripts' merger with Medco Health. The results also topped street consensus sales estimates of $25.55 billion. Looking ahead, the company lifted its full-year adjusted earnings view. Express Scripts now sees EPS of $4.23 to $4.33 versus its previous guidance of $4.20 to $4.30. Currently, Wall Street analysts anticipate that the company will report earnings per share of $4.26 for fiscal 2013.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.